A DRUG prescribed to thousands of Brits a could reduce the risk of a heart attack or stroke, according to a new study.

Approximately 950,000 people in Germany have been diagnosed with gout. About eight out of ten patients are male, and the disease typically appears after the age of 40. FITBOOK explores the causes of ...

Shortly after arriving in Korea, I developed an ingrown toenail and went to a hospital. “You’ve got an ingrowing toenail,” ...

SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

Gout, a curable arthritis, now aims for long-term remission over flare control. Professors Towiwat and Li's review in the ...

Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular ...

A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...

Scientists at Georgia State University have used CRISPR gene editing to restore an ancient enzyme humans lost millions of years ago potentially reversing the buildup of uric acid that causes gout.

DelveInsight's“ Gout Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Gout pipeline landscape. It covers the Gout Pipeline drug profiles, ...

A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according ...

Trial results showed that 60-minute pegloticase infusions plus MTX had comparable safety and efficacy to standard 120-minute protocols for managing uncontrolled gout.

SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people ...